Webiner on “Cell Therapy Approaches for Urethral Stricture” jointly held with Edogawa Hospital
1/10/2022
国際ウェビナー「尿道狭窄症に対する細胞治療アプローチ」を江戸川病院と共同開催します。
Press release
Paper on Potential of Beta-Glucan Products to Prevent and Treat Non-Alcoholic Fatty Liver Disease
1/10/2022
非アルコール性脂肪肝に関する研究の論文が免疫専門ジャーナルに掲載されました。
Tackling long COVID-19, with safety proven Japanese Beta Glucans; The first clinical report in the world
8/10/2021
The first report of Beta glucan food supplements y…
Path-breaking feat of reversing in-vitro aging of human chondrocytes; published in Scientific Reports, a Nature Journal.
10/7/2021
Our 3D-TGP platform based method cultures chondroc…
New Advances in Regenerative Treatments for Cartilage Injuries Published in THE KNEE
11/3/2021
GNC succeeded in culturing hyaluronic acid-rich chondrocytes in a 3D tissue engineering platform.
The Potential of Nichi Glucan as a Vaccine Adjuvant
7/3/2021
A paper describing the potentials of Nichi Glucan as Vaccine Ajuvant is published.
News
Value addition to Japanese technologies by GN Corp, featured in Government of Japan official website
10/5/2022
Please visit the site https://www.japan.go.jp/econ…
A study of Nichi Glucan on children with autism has been published in Research Features Magazine
10/5/2022
A study of nitiglucan on children with autism has …
Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement
6/3/2022
A breakthrough achievement published in Life Scien…
Patent
Obtained Japanese patent for A method of enhancement of the immune cells and blood cells
7/10/2020
GN Corporation Co Ltd obtained a Japanese patent N…
Obtained Japanese patent for Urethral Stricture Treatment by Hybrid Cell Therapy
2/7/2020
Obtained Japanese patent for Urethral Stricture Treatment